Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,796 signal articles · 215 in last 24h · 134,798 total before filter · latest 55m ago
215last 24h
1081last 7d
177● bullish (7d)
138● bearish (7d)
209publishers
AllMacro293Earnings344M&A75Regulatory25Product11Analyst15
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
MongoDB’s (NASDAQ:MDB) Q2 CY2026: Strong Sales But Stock Drops 13.7%
StockStory2d agobearish
MongoDB’s (NASDAQ:MDB) Q2 CY2026: Strong Sales But Stock Drops 13.7%

Database platform company MongoDB (NASDAQ:MDB) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 30.5% year on year to $771.8 million. Guidance for next quarter’s revenue was better than expected at $758.5 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $1.90 per share was 18.1% above analysts’ consensus estimates.

Hims & Hers falls after FDA crackdown on unapproved weight-loss drugs
Proactive2d agobearish
Hims & Hers falls after FDA crackdown on unapproved weight-loss drugs

Hims & Hers Health (NYSE:HIMS) shares fell 3.2% after the FDA warned telehealth companies and compounding pharmacies over unapproved weight-loss drugs, including versions of semaglutide, tirzepatide and retatrutide. The agency said retatrutide and cagrilintide cannot legally be used in...